Search results for “Fatty liver” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 5,821 patents, we discovered top 456 key players by total patent application. Wellstat Therapeutics Corp., Eli Lilly & Co., Alnylam Pharmaceuticals, Inc. are dominant in this area. They take 7.25% of the total patent filing.
United States
Patent: 252
Indiana, United States
Patent: 101
Massachusetts, United States
Patent: 69
South Korea
Patent: 69
California, United States
Patent: 58
Berlin, Germany
Patent: 58
Tianjin Shi, China
Patent: 53
France
Patent: 52
Rheinland-Pfalz, Germany
Patent: 46
South Korea
Patent: 44
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 177 patents, we discovered top 28 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, ImmunoMet Therapeutics, Inc., TrueBinding, Inc. are active in this area.
STARTUP
France
Patent: 37
STARTUP
Texas, United States
Patent: 22
STARTUP
California, United States
Patent: 15
STARTUP
South Korea
Patent: 10
STARTUP
California, United States
Patent: 9
STARTUP
South Korea
Patent: 8
STARTUP
DUBLIN, Ireland
Patent: 8
STARTUP
Massachusetts, United States
Patent: 8
STARTUP
South Korea
Patent: 7
California, United States
Patent: 5
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 3,651 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Eli Lilly & Co., Amgen, Inc., Alnylam Pharmaceuticals, Inc. take 5.07% of patent filing during this period.
Indiana, United States
Patent: 79
California, United States
Patent: 58
Massachusetts, United States
Patent: 48
Shanghai Shi, China
Patent: 43
Gyeonggi-do, South Korea
Patent: 36
California, United States
Patent: 31
STARTUP
France
Patent: 30
Jiangsu Sheng, China
Patent: 28
Massachusetts, United States
Patent: 28
France
Patent: 27
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 3,651 patents in last 5 years, we discover 288 new entrants. Amgen, Inc., Shanghai Qilu Ruige Pharmaceutical R&D Co. Ltd., Arrowhead Pharmaceuticals, Inc. are the most active new entrants in this area.
California, United States
Patent: 58
Shanghai Shi, China
Patent: 43
California, United States
Patent: 31
Massachusetts, United States
Patent: 28
Gyeonggi-do, South Korea
Patent: 25
Nordrhein-Westfalen, Germany
Patent: 23
California, United States
Patent: 21
Virginia, United States
Patent: 21
France
Patent: 15
STARTUP
California, United States
Patent: 15
Research Institutions
Order by:
Innovation Intensity
With the analysis among 2,413 patents, we discovered top 261 universities and scientific research institutions by total patent application. China Pharmaceutical University, Wuhan University, Consejo Superior de Investigaciones Científicas are dominant in this area. They take 9.41% of the total patent filing.
Jiangsu Sheng, China
Patent: 48
Hubei Sheng, China
Patent: 44
Madrid, Spain
Patent: 40
Massachusetts, United States
Patent: 35
New Hampshire, United States
Patent: 33
Virginia, United States
Patent: 33
Shanghai Shi, China
Patent: 27
Shanghai Shi, China
Patent: 27
Jiangsu Sheng, China
Patent: 26
Hiroshima-ken, Japan
Patent: 21
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: